Infinory Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Investors
  • 3

Infinory General Information

Description

Developer of oncolytic virus-based biopharmaceutical technologies designed for first-in-class anticancer drug innovation. The company is built on engineered oncolytic adenoviruses supported by leading serum-free suspension manufacturing processes, validated antitumor activity, intravenous delivery capabilities, and expert-led R&D in virology and gene therapy, enabling oncology researchers and clinicians to advance multiple Class I innovative drug candidates including a Phase II oncolytic virus program with demonstrated efficacy accelerate clinical translation, expand therapeutic options, and prepare products for clinical grade production at globally competitive standards.

Contact Information

Website
www.in-finory.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 11, Suzhou Life and Health Town Industrial Park
  • Number 168 Majian Road, Huqiu District
  • Suzhou, Jiangsu 215011
  • China
+86 400
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Oncology
Corporate Office
  • Building 11, Suzhou Life and Health Town Industrial Park
  • Number 168 Majian Road, Huqiu District
  • Suzhou, Jiangsu 215011
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Infinory Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 29-Apr-2026 Completed Generating Revenue
5. Later Stage VC 10-Sep-2024 Completed Generating Revenue
4. Later Stage VC (Series B) 01-Jun-2025 Completed Generating Revenue
3. Early Stage VC (Series A1) 01-Feb-2024 Completed Clinical Trials - Phase 1
2. Early Stage VC 01-Sep-2021 Completed Clinical Trials - Phase 1
1. Early Stage VC 01-Apr-2021 Completed Clinical Trials - Phase 1
To view Infinory’s complete valuation and funding history, request access »

Infinory Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sunbow Capital Asset Manager Minority
Harmony Invest Venture Capital Minority
Hangzhou Shenghui Jingchen Investment Management Growth/Expansion Minority
To view Infinory’s complete investors history, request access »

Ready to get started?

Request a free trial

Infinory FAQs

  • When was Infinory founded?

    Infinory was founded in 2020.

  • Where is Infinory headquartered?

    Infinory is headquartered in Suzhou, China.

  • What industry is Infinory in?

    Infinory’s primary industry is Drug Discovery.

  • Is Infinory a private or public company?

    Infinory is a Private company.

  • What is Infinory’s current revenue?

    The current revenue for Infinory is .

  • Who are Infinory’s investors?

    Sunbow Capital, Harmony Invest, and Hangzhou Shenghui Jingchen Investment Management have invested in Infinory.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process